Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82)

Veterinary Journal

Volumn 182, Issue 1, 2009, Pages 100-107

  Puff, Christina ^a   Krudewig, Christiane ^a   Imbschweiler, Ilka ^a   Baumgärtner, Wolfgang ^a   Alldinger, Susanne ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Canine distemper virus; Cell line; Matrix metalloproteinases; RECK; TIMP

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; MEMBRANE PROTEIN; ONCOLYTIC VIRUS; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CONTROLLED STUDY; DOG; DOWN REGULATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; MACROPHAGE; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOLYTIC VIROTHERAPY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION; ZYMOGRAPHY;

ANIMALS; CELL LINE, TUMOR; DISTEMPER; DISTEMPER VIRUS, CANINE; DOGS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASES;

CANINE DISTEMPER VIRUS; MORBILLIVIRUS;

EID: 67349163999     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.03.026     Document Type: Article

References (41)

1. Ala-Aho R., Johansson N., Baker A.H., and Kahari V.M. Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells. International Journal of Cancer 97 (2002) 283-289
2. Barnes A., Bee A., Bell S., Gilmore W., Mee A., Morris R., and Carter S.D. Immunological and inflammatory characterisation of three canine cell lines: K1, K6 and DH82. Veterinary Immunology and Immunopathology 75 (2000) 9-25
3. Bjorklund M., and Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochimica et Biophysica Acta 1755 (2005) 37-69
4. Cazorla M., Hernandez L., Nadal A., Balbin M., Lopez J.M., Vizoso F., Fernandez P.L., Iwata K., Cardesa A., Lopez-Otin C., and Campo E. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. Journal of Pathology 186 (1998) 144-150
5. Clark J.C., Thomas D.M., Choong P.F., and Dass C.R. RECK - a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Reviews 26 (2007) 675-683
6. Corcoran M.L., and Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. Journal of Biological Chemistry 270 (1995) 13453-13459
7. Culhaci N., Metin K., Copcu E., and Dikicioglu E. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness. BMC Cancer 4 (2004) 42
8. Fielding A.K. Measles as a potential oncolytic virus. Reviews in Medical Virology 15 (2005) 135-142
9. Freije J.M., Balbin M., Pendras A.M., Sanchez L.M., Puente X.S., and Lopez-Otin C. Matrix metalloproteinases and tumor progression. Advances in Experimental Medicine and Biology 532 (2003) 91-107
10. Gentilini F., Calzolari C., Turba M.E., Agnoli C., Fava D., Forni M., and Bergamini P.F. Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma affected dogs. Leukemia Research 29 (2005) 1263-1269
11. Gröne A., Fonfara S., and Baumgärtner W. Cell type-dependent cytokine expression after canine distemper virus infection. Viral Immunology 15 (2002) 493-505
12. Grote D., Russell S.J., Cornu T.I., Cattaneo R., Poland G.A., and Fielding A.K. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97 (2001) 3746-3754
13. Gröters S., Alldinger S., and Baumgärtner W. Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephalitis. Acta Neuropathologica 110 (2005) 369-382
14. Guedez L., Mansoor A., Birkedal-Hansen B., Lim M.S., Fukushima P., Venzon D., Stetler-Stevenson W.G., and Stetler-Stevenson M. Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood 97 (2001) 1796-1802
15. Haupt L.M., Thompson E.W., Trezise A.E., Irving R.E., Irving M.G., and Griffiths L.R. In vitro and in vivo MMP gene expression localisation by in-situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts. BMC Cancer 24 (2006) 18
16. Hayakawa T., Yamashita K., Ohuchi E., and Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). Journal of Cell Science 107 (1994) 2373-2379
17. Johansson N., Vaalamo M., Grenman S., Kariniemi L., Saarialhokere U., and Kahari V.M. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. American Journal of Pathology 154 (1999) 469-480
18. Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. Journal of the National Cancer Institute 86 (1994) 299-304
19. Kim J.R., and Kim C.H. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells. International Journal of Biochemistry and Cell Biology 36 (2004) 2293-2306
20. Knäuper V., Will H., Lopez-Otin C., Smith B., Atkinson S.J., Stanton H., Hembry R.M., and Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. Journal of Biological Chemistry 271 (1996) 17124-17131
21. Kossakowska A.E., Urbanski S.J., and Janowska-Wieczorek A. Matrix metalloproteinases and their tissue inhibitors - expression, role and regulation in human malignant non-Hodgkin's lymphomas. Leukemia and Lymphoma 39 (2000) 485-493
22. Liu L.T., Peng J.P., Chang H.C., and Hung W.C. RECK is a target of Epstein-Barr virus latent membrane protein 1. Oncogene 22 (2003) 8263-8270
23. Luparello C., Avanzato G., Carella C., and Pucci-Minafra I. Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells. Breast Cancer Research and Treatment 54 (1999) 235-244
24. Miao Q., Baumgärtner W., Failing K., and Alldinger S. Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis. Acta Neuropathologica 106 (2003) 486-494
25. Nakopoulou L., Katsarou S., Giannopoulou I., Alexandrou P., Tsirmpa I., Panayotopoulou E., Mavrommatis J., and Keramopoulos A. Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer. Modern Pathology 15 (2002) 26-34
26. Oh J., Takahashi R., Kondo S., Mizoguchi A., Adachi E., Sasahara R.M., Nishimura S., Imamura Y., Kitayama H., Alexander D.B., Ide C., Horan T.P., Arakawa T., Yoshida H., Nishikawa S., Itoh Y., Seiki M., Itohara S., Takahashi C., and Noda M. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107 (2001) 789-800
27. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology 132 (2000) 365-386
28. Sasahara R.M., Takahashi C., Sogayar M.C., and Noda M. Oncogene-mediated down-regulation of RECK, a novel transformation suppressor gene. Brazilian Journal of Medical and Biological Research 32 (1999) 891-895
29. Seehusen F., Orlando E.A., Wewetzer K., and Baumgärtner W. Vimentin-positive astrocytes in canine distemper: a target for canine distemper virus especially in chronic demyelinating lesions?. Acta Neuropathologica 114 (2007) 597-608
30. Song S.Y., Son H.J., Nam E., Rhee J.C., and Park C. Expression of reversion-inducing-cysteine-rich-protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer. European Journal of Cancer 42 (2006) 101-108
31. Span P.N., Sweep C.G., Manders P., Beex L.V., Leppert D., and Lindberg R.L. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer 97 (2003) 2710-2715
32. Stetler-Stevenson M., Mansoor A., Lim M., Fukushima P., Kehrl J., Marti G., Ptaszynski K., Wang J., and Stetler-Stevenson W.G. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 89 (1997) 1708-1715
33. Suter S.E., Chein M.B., von Messling V., Yip B., Cattaneo R., Vernau W., Madewell B.R., and London C.A. In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma. Clinical Cancer Research 11 (2005) 1579-1587
34. Takagi S., Kitamura T., Hosaka Y., Ohsaki T., Bosnakovski D., Kadosawa T., Okumura M., and Fujinaga T. Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK. Journal of Veterinary Medical Science 67 (2005) 385-391
35. Takagi S., Kata Y., Asano K., Ohsaki T., Bosnakovski D., Hoshino Y., Okumura M., Kadosawa T., and Fujinaga T. Matrix metalloproteinase inhibitor RECK expression in canine tumors. The Journal of Veterinary Medical Science 67 (2005) 761-767
36. Takahashi C., Sheng Z., Horan T.P., Kitayama H., Maki M., Hitomi K., Kitaura Y., Takai S., Sasahara R.M., Horimoto A., Ikawa Y., Ratzkin B.J., Arakawa T., and Noda M. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 13221-13226
37. Takenaka K., Ishikawa S., Yanagihara K., Miyahara R., Hasegawa S., Otake Y., Morioka Y., Takahashi Y., Noda M., Ito H., Wada H., and Tanaka F. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer. Annals of Surgical Oncology 12 (2005) 817-824
38. Takeuchi T., Hisanaga M., Nagao M., Ikeda N., Jujii H., Koyama F., Mukogawa T., Matsumoto H., Kondo S., Takahashi C., Noda M., and Nakajima Y. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clinical Cancer Research 10 (2004) 5572-5579
39. von Smolinski D., Leverköhne I., von Samson-Himmelstjerna G., and Gruber A.D. Impact of formalin-fixation and paraffin-embedding on the ratio between mRNA copy numbers of differently expressed genes. Histochemistry and Cell Biology 124 (2005) 177-188
40. Wellman M.L., Krakowka S., Jacobs R.M., and Kociba G.J. A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cellular and Developmental Biology 24 (1988) 223-229
41. Würtz S.Ø., Schrohl A.S., Møller Sørensen N., Lademann U., Christensen I.J., Mouridsen H., and Brünner N. Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocrine-Related Cancer 12 (2005) 215-227